Skip to main content

Table 3 Physical activity as measured by accelerometer and RPAQ questionnaire

From: Developing a complex intervention for diet and activity behaviour change in obese pregnant women (the UPBEAT trial); assessment of behavioural change and process evaluation in a pilot randomised controlled trial

  

Control

Intervention

Treatment effect

By Accelerometer

n: baseline, 28 weeks

n = 72, 39

n = 68, 36

 

Sedentary

Baseline

1172 (95)

1165 (91)

 

28 weeks

1175 (86)

1197 (77)

21 (−13 to 55)

Active

Baseline

217 (65)

225 (58)

 

28 weeks

209 (82)

194 (68)

−11 (−42 to 19)

Light

Baseline

178 (54)

184 (50)

 

28 weeks

175 (81)

161 (61)

−9 (−38 to 19)

MVPA

Baseline

40 (20)

42 (20)

 

28 weeks

34 (18)

33 (15)

−2 (−9 to 5)

By RPAQ Questionnaire

n: baseline, 28 weeks

n = 80, 54

n = 79, 56

 

Sedentary

Baseline

1007(207)

1009 (187)

 
 

28 weeks

1068(177)

1020 (226)

−50 (−115 to 16)

Active

Baseline

408 (189)

415 (180)

 
 

28 weeks

367 (175

410 (219)

45 (−16 to 106)

Light

Baseline

354 (180)

356 (164)

 
 

28 weeks

333 (165)

340 (204)

11 (−46 to 68)

MVPA

Baseline

54 (87)

60 (99)

 
 

28 weeks

34 (52)

70 (78)

34 (9 to 59)

  1. Abbreviations: MVPA, Moderate and/or vigorous physical activity; RPAQ, Recent Physical Activity Questionnaire.
  2. Results are measured in minutes/day presented as mean (SD). Treatment effects are mean differences (95% confidence intervals), adjusted for baseline activity; with dummy variables where baseline levels missing (2 accelerometer, 3 RPAQ).